首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer Medicine

Cancer Medicine杂志,由John Wiley and Sons Ltd出版,于2012年创刊,12 issues/year,出版语言English,ISSN:2045-7634,E-ISSN:2045-7634。

投稿咨询
Cancer Medicine
Cancer Medicine
Cancer Medicine
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.5
CiteScore
5.7
期刊收录
SCI、SCIE

Cancer Medicine(中文译名:《癌症医学》),ISSN:2045-7634,EISSN:2045-7634,是John Wiley and Sons Ltd出版的国际性学术期刊,创刊于2012年,以12 issues/year形式稳定发行,2026年总发文量约924篇。该刊采用OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.5,2025年期刊CiteScore为5.7,2025年期刊自引率约2.9%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Cancer Medicine长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期19 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Japan、India、Canada、France、GERMANY (FED REP GER)等为核心发文国家与地区;FUDAN UNIVERSITYSUN YAT SEN UNIVERSITY、NANJING MEDICAL UNIVERSITY、STATE KEY LAB ONCOLOGY SOUTH CHINA、UNIVERSITY OF TEXAS SYSTEM、CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING UNION MEDICAL COLLEGE、HARVARD UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 142 / 333

57.5

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 151 / 322

53.3

学科:ONCOLOGY SCIE Q2 141 / 322

56.37


中国学者近期发文

1
The Clinical Relevance of Lymph Node Ratio for Post-Mastectomy Radiotherapy in Triple-Negative Breast Cancer: A Real-World Analysis With Propensity Score Matching Using SEER Databas

Author:Zheng, Wei-Hong; Sun, Jia-Yuan; Kou, Jia; Li, Feng-Yan; Li, Guan-Qiao; Wu, San-Gang; He, Zhen-Yu

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71882

2
Identification of Prognostic Risk Factors in Older Patients With Extensive-Stage Small Cell Lung Cance

Author:Liu, Jiayin; Liu, Xun; Li, Xiaolin; Liu, Ning; Wang, Bo; Feng, Li; Fan, Zhisong; Wang, Long; Han, Jing; Zhang, Xue; Jin, Hui; Li, Dan; Liu, Yan; Zuo, Jing; Wang, Yudong

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71885

3
Neoadjuvant Immunochemotherapy Increases the Abundance of Tertiary Lymphoid Structures and Lymphocyte Subpopulations Is Associated With Prognosis of Esophageal Squamous Cell Carcinom

Author:Li, Ning; Zhang, Xiaoyan; Tang, Xupeng; Shen, Juanning; Qi, Qing; Wu, Huili; Zhao, Yuze; Wang, Shuo

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71889

4
Integration Analysis of Bayesian and Machine Learning for Heterogeneity, Biomarkers, and Optimal Combination Regimens of Pucotenlimab in Solid Tumor

Author:He, Yingge; Gao, Changqing; Zhang, Shiyan; Hao, Yonghui; He, Shuning; Peng, Ke; Li, Liqi

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71893

5
Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Tria

Author:Wang, Jie; Li, He; Lin, Qiaochu; Guo, Yong; Ma, Hongbing; Xiang, Bing; Yang, Chenlu; Shen, Kai; Zhang, Chunlan; Yang, Kun; Ma, Chunrong; Zhai, Hong; Wei, Jin; Zuo, Yan; Zhou, Jie; Niu, Ting

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71821

6
Impact of Underlying Liver Disease on the Risk and Prognostic Factors of Breast Cancer Liver Metastases: A Retrospective Multicenter Cohort Stud

Author:Wang, Xiaowen; Zhang, Yuan; Yang, Qiwei; Yang, Luo; Wang, Yanhui; Zeng, Xiangxin; Zou, Long; Guo, Yujuan; Zhou, Wenyang; Jiang, Yuqi; Wu, Jiezhong; Zhang, Peng; Zhou, Song; Zheng, Guangjuan; Huang, Tao; Wang, Genshu; Hu, Kunpeng

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71761

7
A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi-Center Retrospective Stud

Author:Tian, Chenfan; Zeng, Na; Tu, Yuan; Gong, Chunxia; Yu, Jiaxin; Rao, Kunying; Jiang, Peng

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71876

8
An XGBoost-Based Multicenter Model for Predicting HBV-Related Hepatocellular Carcinoma: Development and Validatio

Author:Lin, Yong; Zhuo, Hai-Yan; Song, Hui-Wen; Zhou, Li-Na; Hong, Mei-Zhu; Lin, Chun; Guo, Peng-Fei; Pan, Jin-Shui

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 5, pp. -. DOI: 10.1002/cam4.71887

9
Clinical Characteristics and Prognostic Prediction of Secondary Solid Malignancies in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphom

Author:Zhang, Lulu; Tian, Jiahao; Xiong, Qunli; Ye, Haimei; Wang, Zhao; Wang, Yu; Guo, Chengcheng; Huang, He

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cam4.71844

10
Research on Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Therapy in cN1 Breast Cancer Patient

Author:Shang, Jiabei; Chen, Jianzhe; Zheng, Ruchun; Huang, Zhaoyu; Wu, Xinrui; Min, Jie; Chen, Maoshan; Quan, Yi; Wu, Bin; Zuo, Huaiquan; Fu, Hua; Wan, Yuepin; Bai, Jiao; Pan, Guangrui

Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cam4.71845


在线咨询

Cancer Medicine

国际简称:CANCER MED-US参考译名:癌症医学

年发文量:924 CiteScore:5.7 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:84.96%

杂志社联系方式:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Cancer Medicine